Expressive dysphasia possibly related to FK506 in two liver transplant recipients.

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Transplantation

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 1701571PMCID PMC2966280
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Liver, Kidney, and Thoracic Organ Transplantation Under FK 506

  1990cited by this paper
• Kidney transplantation under FK 506.

  1990cited by this paper
• Cyclosporine central neurotoxicity following renal transplantation. Report of a case using magnetic resonance images.

  1990cited by this paper
• Central pontine myelinolysis after liver transplantation

  1989cited by this paper
• Pontine and extrapontine myelinolysis following liver transplantation. Relationship to serum sodium.

  1989cited by this paper
• A receptor for the immuno-suppressant FK506 is a cis–trans peptidyl-prolyl isomerase

  1989cited by this paper
• A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin

  1989cited by this paper
• Central nervous system toxicity after liver transplantation. The role of cyclosporine and cholesterol.

  1987cited by this paper
• Aluminium overload, a predisposing condition for epileptic seizures in renal-transplant patients treated with cyclosporin?

  1985cited by this paper
• Association between cyclosporin neurotoxicity and hypomagnesaemia.

  1984cited by this paper
• Acute Neurological Complications After Liver Transplantation with Particular Reference to Intraoperative Cerebral Air Embolus

  1978cited by this paper
• Liver bypass and the glia.

  1974cited by this paper

• Tacrolimus-associated neurotoxicity isolated to the brainstem: two illustrative cases and a systematic review of the literature

  2024cites this paper
• Tacrolimus induced diffuse pontine hyperintensity in status epilepticus: a rare entity

  2020cites this paper
• Osmotic Demyelination Syndrome Following Hyponatremia-Oriented Management in Liver Transplant: A Single Center 20-Year Experience.

  2019cites this paper
• Neurologic complications in kidney transplant recipients.

  2017cites this paper
• Different Effects of Tacrolimus on Innate and Adaptive Immune Cells in the Allograft Transplantation

  2016cites this paper
• Late onset of progressive speech impairment due to tacrolimus-associated leukoencephalopathy after kidney transplantation

  2015cites this paper
• Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Single-Center Study

  2015cites this paper
• Identifying Risk Factors for Central Pontine and Extrapontine Myelinolysis After Liver Transplantation: A Case–Control Study

  2014cites this paper
• Neurologic complications of liver transplantation.

  2014cites this paper
• One Thousand Consecutive Primary Liver Transplants Under Tacrolimus Immunosuppression: A 17- to 20-Year Longitudinal Follow-Up

  2011cites this paper
• Mutism and Persistent Dysarthria Due to Tacrolimus-Based Immunosuppression Following Allogeneic Liver Transplantation

  2011cites this paper
• Central pontine myelinolysis (CPM) associated with tacrolimus (FK506) after liver transplantation.

  2011cites this paper
• Neurologic complications in adult living donor liver transplant recipients

  2007cites this paper
• Catatonic mutism after liver transplant rapidly reversed with lorazepam.

  2007cites this paper
• Neuropsychiatric Complications After Liver Transplantation: Role of Immunosuppression and Hepatitis C

  2006cites this paper
• Cyclosporine-associated leukoencephalopathy in organ transplant recipients: experience of three clinical cases.

  2006cites this paper
• Central pontine myelinolysis after living donor liver transplantation.

  2004cites this paper
• Tacrolimus (FK506)-induced mutism after liver transplant.

  2003cites this paper
• Speech disorder related to tacrolimusinduced pontine myelinolysis after orthotopic liver transplantation

  2003cites this paper
• Speech disorder related to tacrolimus-induced pontine myelinolysis after orthotopic liver transplantation

  2003cites this paper
• Tacrolimus-induced neurotoxicity in kidney transplant recipients.

  2002cites this paper
• Neurologic Complications of Transplantation

  2002cites this paper
• Cortical laminar necrosis caused by immunosuppressive therapy and chemotherapy.

  2000cites this paper
• Speech disturbances in a child after living related liver transplant.

  2000cites this paper
• Immunosuppressive Therapy and Chemotherapy Cortical Laminar Necrosis Caused by

  2000cites this paper
• Reversible tacrolimus-induced neurotoxicity isolated to the brain stem.

  2000cites this paper
• What have we learned about primary liver transplantation under tacrolimus immunosuppression? Long-term follow-up of the first 1000 patients.

  1999cites this paper
• Tacrolimus (FK506)-induced severe and late encephalopathy in a renal transplant recipient.

  1999cites this paper
• Immunosuppressive-associated leukoencephalopathy in organ transplant recipients.

  1999cites this paper
• Early complications after orthotopic liver transplantation.

  1999cites this paper
• Tacrolimus ( FK 506 )-induced severe and late encephalopathy in a renal transplant recipient

  1999cites this paper
• What Have We Learned About Primary Liver Transplantation Under Tacrolimus Immunosuppression?

  1999cites this paper
• The side-effects of ciclosporine-A and tacrolimus.

  1998cites this paper
• Central nervous system lesions in liver transplant recipients: prospective assessment of indications for biopsy and implications for management.

  1998cites this paper
• The neuropathology of organ transplantation: comparison and contrast in 500 patients.

  1998cites this paper
• FK506-induced fulminant leukoencephalopathy after single-lung transplantation.

  1997cites this paper
• Reply from the Authors

  1997cites this paper
• Dysarthria and apraxia of speech associated with FK-506 (tacrolimus).

  1996cites this paper
• Cyclosporine-associated mutism in liver transplant patients

  1996cites this paper
• Different aetiologies of reversible MRI abnormalities in transplant recipients.

  1996cites this paper
• Cyclosporin and Tacrolimus in Clinical Transplantation

  1996cites this paper
• Immunosuppression‐induced leukoencephalopathy from tacrolimus (FK506)

  1996cites this paper
• Acute disseminated encephalomyelitis (ADEM) or ADEM-like inflammatory changes in a heart-lung transplant recipient: a case report

  1995cites this paper
• The Treatment of Intractable Rejection with Tacrolimus (FK506) in Pediatric Liver Transplant Recipients

  1995cites this paper
• Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506.

  1994cites this paper
• Neurological examinations after liver transplantation concerning patients under corticosteroid immunosuppression and either FK 506 or cyclosporin

  1994cites this paper
• Early weight loss and high serum tumor necrosis factor‐α levels in polyneuropathy, organomegaly, endocrinopathy, M protein, skin changes syndrome

  1994cites this paper
• FK506‐induced neurotoxicity in liver transplantation

  1994cites this paper
• FK506 (tacrolimus), a novel immunosuppressant in organ transplantation: clinical, biomedical, and analytical aspects.

  1993cites this paper
• Adverse effects of FK 506 overdosage after liver transplantation.

  1993cites this paper
• Tacrolimus. A review of its pharmacology, and therapeutic potential in hepatic and renal transplantation.

  1993cites this paper
• The neuropathology of liver transplantation: comparison of main complications in children and adults.

  1993cites this paper
• Pontine myelinolysis following liver transplantation: a report of two cases

  1993influential citation
• THE EFFECT OF GRAFT FUNCTION ON FK506 PLASMA LEVELS, DOSAGES, AND RENAL FUNCTION, WITH PARTICULAR REFERENCE TO THE LIVER

  1991cites this paper
• Neurologic complications of FK 506.

  1991cites this paper
• FK 506: an immunosuppressant for the 1990s?

  1991cites this paper
• Isolated to the Brain Stem Reversible Tacrolimus-induced Neurotoxicity

  year unknowncites this paper